Rare diseases
Investigational molecules
Locations
Study of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer
ItalyStudy of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer
ItalyStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
ItalyStudy of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer
ItalyStudy on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
ItalyStudy of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation
ItalyStudy Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ItalyStudy on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis
ItalyStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
ItalyStudy of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment
ItalyStudy of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy
ItalyStudy of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
